Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Researchers programme phages to fight pathogens
Zurich – Researchers at the Federal Institute of Technology (ETH) in Zurich have developed a technology platform that allows them to systematically modify bacteriophages. This marks a major step towards uses phages for therapeutic purposes.
Zedra to open office in Greater Zurich Area
Zurich – Global finance company Zedra will open an office in Zurich in an effort to build its presence in the German-speaking region.
InSphero participates in nanosecurity project
Schlieren ZH - InSphero is participating in an international project to develop safety testing methods for engineered nanomaterials. The aim is to reduce the materials' damaging effect on people and the environment.
U.S. innovation center cooperates with Kenzen
Zizers GR/Santa Clara - The U.S. technology corporation Gore's Innovation Center is joining forces with Kenzen. The partners intend to develop a wearable system that continuously monitors health.
ETH advances medication research
Zurich – Scientists at the ETH have developed a method that increases understanding of the interaction between proteins and metabolic molecules. It could bring great benefits to the pharmaceutical industry. Biognosys is the exclusive license holder.
Cold virus redesigned for cancer therapy
Zurich – Researchers at the University of Zurich have redesigned a cold virus for use in cancer gene therapy. The virus can hide behind a protein shield and specifically infect tumor cells.
Record level of VC investment in Switzerland
Zurich – Funding for Swiss startups reached a new record high in 2017. The greatest rise was reported for venture capital investment in fintechs in the area of digitalisation, while biotech and medtech continued to receive the highest amounts. Growth was particularly strong in the canton of Zurich.
Ava bracelet confirms ovulation
Zurich – Medtech startup Ava now also provides users of its bracelet with insights into whether they have ovulated during a monthly cycle. In addition, it is launching a clinical trial into the detection of infections during pregnancy.
New technique gives new hope for improved anti-epilepsy medication
Zurich – Researchers in Zurich have developed a technique that uses electrical brain signals to more precisely evaluate the effects of medications on the brain. It could prove useful in the early development phase of anti-epilepsy medication.
Meet with an expansion expert
Is Greater Zurich on your expansion radar? We support you on every step of your expansion journey - from location evaluation to fact finding visits.
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Location evaluation support to find the ideal base for your business
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space
- And much more, customized to meet your needs.